European Union: New approval of Substances of Human Origin Regulation

In brief

The Council and European Parliament have approved the EU Regulation on Substances of Human Origin. This new piece of legislation establishes a set of revised and harmonized rules aimed at providing stricter and higher standards to ensure quality and safety of organs, blood and blood derivatives, in order to protect organ donors, organ recipients and offspring of patients undergoing assisted reproduction, without losing sight of the need to provide a suitable and effective framework for innovation.


Contents

In more detail 

Introduction

On 17 July, the Regulation (EU) 2024/1928 on standards of quality and safety for substances of human origin intended for human application ("SoHO Regulation") was published in the Official Journal of the European Union. This new Regulation offers a wider and more exhaustive set of standards in relation to Substances of Human Origin ("SoHO"), until now contained in Directive 2002/98/EC, on setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components, and Directive 2004/23/EC, on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells ("Directives"), which will be repealed. One of the main novelties is the harmonization of the regulations in a single text, which provides a complete and uniform regulatory framework for Member States, avoiding divergence and different criteria on a national level. The SoHO Regulation will be applicable from August 2027 and will establish a regulatory framework with minimum provisions, without prejudice to Member States deciding to adopt more rigorous measures than those contained in these new legislation.

A broader scope

One of the most important aspects of the SoHO Regulation is its scope of application. From now on, and breaking with the diversity of regulatory sources existing to this date, we will have a regulation that aims to cover all types of substances of human origin in a single regulatory text. By way of example, the new SoHO regulation will apply not only to blood and blood components, human tissues and cells, which were already subject to previous regulation, but also to breast milk, intestinal microbiota and blood preparations that are not used for transfusion purposes.

Notwithstanding the above, this new regulation still maintains the premise that only substances that involve a biological interaction with the human body will be understood to fall within its scope. Nevertheless, the SoHO Regulation also includes an open clause mentioning "any other SoHO that may be applied to humans in future", so it is foreseeable that the list of substances will be extended in the forthcoming years.

Higher safety and quality standards

From a safety perspective, the SoHO Regulation seeks to extend its protective nature to individuals who were not previously considered. Under the previous Directives there was a risk of leaving certain groups of people unprotected due to the lack of regulation of certain SoHO. This situation has been remedied by, the SoHO Regulation, which shall be applicable to both donors and offspring born from medically assisted reproduction techniques, guaranteeing them a high standard of protection.

By introducing the relevant authorization as a prerequisite, higher safety standards are upheld. We would like to highlight the following:

  • Any processing of SoHO that includes its transformation is subject to an appropriate level of supervision, in addition to the obligation to obtain authorization for its distribution and application.
  • Laboratories and departments responsible for quality controls shall be registered as SoHO entities.
  • New further criteria and conditions must be considered as to importation and exportation activities involving SoHO. In the case of import, the quality, safety and efficacy of the SoHO must be formally verified. For export, however, a release is required to confirm the quality and safety of the products.

Moreover, the SoHO Regulation regulates high safety and quality standards in comparison to what has been achieved to date. The quality standards is intended to be achieved by future technical guidelines prepared by the European Directorate for the Quality of Medicines & HealthCare and the European Centre for Disease Prevention and Control in relation to the prevention of the transmission of communicable diseases and the protection of recipients of SoHO – to be completed and developed by specific agencies – based on scientific knowledge and up-to-date scientific evidence.

Procedural and institutional novelties

The new SoHO Regulation establishes the obligation for Member States to designate competent and independent authorities to carry out the following activities in the field of SoHO:

  • To authorize SoHO preparations.
  • To perform SoHO supervisory activities.
  • To ensure coordination and communication with the European Commission, other Member States, and their respective national authorities.

Finally, and regarding the abovementioned objective of reaching a better communication between the subjects that fall under the scope of the SoHO Regulation, an ad hoc online platform shall be established – the "EU SoHO Platform" – in order to offer a centralized manner to exchange data and information.

The full content of the SoHO Regulation is available by clicking on the following link. For more information or in case you need individual advice for your company, please contact our team of experts.


Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.